Tourmaline Bio, Inc.
Tourmaline Bio, Inc. (TRML) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 50 transactions totaling $4.0M, demonstrating a bullish sentiment with $4.0M in net insider flow. The most recent transaction on Oct 28, 2025 involved a transaction of 724,664 shares valued at $0.
TRML Insider Activity Summary
Who Is Buying TRML Stock?
No significant insider buying has been recorded for TRML in the recent period.
Who Is Selling TRML Stock?
No significant insider selling has been recorded for TRML in the recent period.
Is Tourmaline Bio, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TRML is bullish with an Insider Alignment Score of 100/100 and a net flow of $4.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TRML Frequently Asked Questions
Understanding TRML Insider Activity
Insider trading at Tourmaline Bio, Inc. (TRML) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading TRML stock, having executed 50 transactions in the past 90 days. The most active insider is Mark Mcdade (Executive), who has made 7 transactions totaling $3.3M.
Related Tools
Track Tourmaline Bio, Inc. Insider Activity
Get notified when executives and directors at TRML file new Form 4 transactions